![](/img/cover-not-exists.png)
Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients
Schluckebier, Luciene, Caetano, Rosangela, Garay, Osvaldo Ulises, Montenegro, Giuliana T., Custodio, Marcelo, Aran, Veronica, Gil Ferreira, CarlosVolume:
20
Journal:
BMC Cancer
DOI:
10.1186/s12885-020-07240-2
Date:
December, 2020
File:
PDF, 757 KB
2020